Linoleyl carnitine
Based on 1 Customer Validation
Linoleyl carnitine is an acylcarnitine and metabolite. Linoleyl carnitine in the liver is negatively correlated with pantothenic acid and citric acid in serum. Linoleyl carnitine accumulates in mitochondrial CPT II deficiency.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 99.94%
- CAS No.: 36816-10-1
- Formule: C25H45NO4
- Masse moléculaire:423.63
-
Stockage:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Pureté et documentation
- Références
-
Help & FAQs
Voir tous les produits spécifiques à Isoform Endogenous Metabolite
More
Activité biologique
Description
IC50 & Target
[1]|
CPT-2 |
Human Endogenous Metabolite |
In Vitro
Linoleyl carnitine in the liver is negatively correlated with pantothenic acid and citric acid in serum. Linoleyl carnitine accumulates in mitochondrial CPT II deficiency[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 36816-10-1
-
Appearance Solid
-
Masse moléculaire 423.63
-
Formule C25H45NO4
-
Color White to yellow
-
SMILES
CCCCC/C=C\C/C=C\CCCCCCCC(O[C@H](CC([O-])=O)C[N+](C)(C)C)=O
-
Structure Classification
-
Initial Source
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Solvant et solubilité
In Vitro:
DMSO : 100 mg/mL (236.06 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pureté et documentation
-
Fiche technique (264 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Instruction de manipulation (2659 KB)
Références
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.3606 mL | 11.8028 mL | 23.6055 mL | 59.0138 mL |
| 5 mM | 0.4721 mL | 2.3606 mL | 4.7211 mL | 11.8028 mL | |
| 10 mM | 0.2361 mL | 1.1803 mL | 2.3606 mL | 5.9014 mL | |
| 15 mM | 0.1574 mL | 0.7869 mL | 1.5737 mL | 3.9343 mL | |
| 20 mM | 0.1180 mL | 0.5901 mL | 1.1803 mL | 2.9507 mL | |
| 25 mM | 0.0944 mL | 0.4721 mL | 0.9442 mL | 2.3606 mL | |
| 30 mM | 0.0787 mL | 0.3934 mL | 0.7869 mL | 1.9671 mL | |
| 40 mM | 0.0590 mL | 0.2951 mL | 0.5901 mL | 1.4753 mL | |
| 50 mM | 0.0472 mL | 0.2361 mL | 0.4721 mL | 1.1803 mL | |
| 60 mM | 0.0393 mL | 0.1967 mL | 0.3934 mL | 0.9836 mL | |
| 80 mM | 0.0295 mL | 0.1475 mL | 0.2951 mL | 0.7377 mL | |
| 100 mM | 0.0236 mL | 0.1180 mL | 0.2361 mL | 0.5901 mL |
Linoleyl carnitine Related Classifications
HY-113256 Related Classifications
Powered by Bioz
Keywords
- Linoleyl carnitine
- 36816-10-1
- Carnitine Palmitoyltransferase (CPT)
- Endogenous Metabolite
- carnitine palmitoyltransferase II
- lipid metabolism
- long-chain fatty acid
- male Wistar rats
- mitochondrial matrix transport
- metabolic disturbance
- oxidative stress
- rat liver tissue
- acrylamide-induced hepatotoxicity
- acylcarnitine
- Inhibitor
- inhibitor
- inhibit